Algernon Pharmaceuticals Inc. (AGN.CN)
CAD 0.08
(6.25%)
CAD 0.08
(6.25%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.19 Million CAD | -48.49% |
| 2022 | 8.14 Million CAD | -19.7% |
| 2021 | 10.13 Million CAD | -20.95% |
| 2020 | 12.82 Million CAD | 140.23% |
| 2019 | 5.33 Million CAD | 275.16% |
| 2018 | 1.42 Million CAD | -13.06% |
| 2017 | 1.63 Million CAD | -28.0% |
| 2016 | 2.27 Million CAD | 985.43% |
| 2015 | 209.42 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 3.89 Million CAD | -1.54% |
| 2024 Q1 | 3.95 Million CAD | -5.78% |
| 2024 Q2 | 3.95 Million CAD | 0.06% |
| 2023 FY | 4.19 Million CAD | -48.49% |
| 2023 Q2 | 6.03 Million CAD | -9.57% |
| 2023 Q4 | 4.19 Million CAD | -31.65% |
| 2023 Q3 | 6.13 Million CAD | 1.67% |
| 2023 Q1 | 6.67 Million CAD | -18.02% |
| 2022 Q2 | 7.78 Million CAD | -8.63% |
| 2022 Q1 | 8.51 Million CAD | -15.98% |
| 2022 FY | 8.14 Million CAD | -19.7% |
| 2022 Q4 | 8.14 Million CAD | 17.92% |
| 2022 Q3 | 6.9 Million CAD | -11.3% |
| 2021 Q1 | 10.23 Million CAD | -20.21% |
| 2021 Q3 | 11.62 Million CAD | 7.58% |
| 2021 FY | 10.13 Million CAD | -20.95% |
| 2021 Q4 | 10.13 Million CAD | -12.81% |
| 2021 Q2 | 10.8 Million CAD | 5.63% |
| 2020 Q2 | 7.71 Million CAD | 13.24% |
| 2020 Q3 | 14.45 Million CAD | 87.46% |
| 2020 Q4 | 12.82 Million CAD | -11.29% |
| 2020 FY | 12.82 Million CAD | 140.23% |
| 2020 Q1 | 6.8 Million CAD | 27.57% |
| 2019 Q1 | 6.46 Million CAD | 354.64% |
| 2019 FY | 5.33 Million CAD | 275.16% |
| 2019 Q2 | 6.07 Million CAD | -6.14% |
| 2019 Q3 | 5.63 Million CAD | -7.27% |
| 2019 Q4 | 5.33 Million CAD | -5.19% |
| 2018 Q3 | 1.46 Million CAD | -11.45% |
| 2018 Q1 | 1.44 Million CAD | -11.96% |
| 2018 Q2 | 1.65 Million CAD | 15.04% |
| 2018 Q4 | 1.42 Million CAD | -3.06% |
| 2018 FY | 1.42 Million CAD | -13.06% |
| 2017 Q4 | 1.63 Million CAD | -14.68% |
| 2017 FY | 1.63 Million CAD | -28.0% |
| 2017 Q2 | 2.68 Million CAD | -12.91% |
| 2017 Q1 | 3.08 Million CAD | 35.81% |
| 2017 Q3 | 1.91 Million CAD | -28.65% |
| 2016 Q1 | 2.88 Million CAD | 105.65% |
| 2016 Q3 | 2.62 Million CAD | -0.01% |
| 2016 Q4 | 2.27 Million CAD | -13.5% |
| 2016 FY | 2.27 Million CAD | 985.43% |
| 2016 Q2 | 2.62 Million CAD | -8.8% |
| 2015 Q4 | 1.4 Million CAD | 0.0% |
| 2015 FY | 209.42 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Asep Medical Holdings Inc | 25.61 Million CAD | 83.626% |
| BetterLife Pharma Inc. | 324.74 Thousand CAD | -1191.378% |
| BioVaxys Technology Corp. | 113.47 Thousand CAD | -3595.605% |
| ChitogenX Inc. | 534 Thousand CAD | -685.337% |
| Rapid Dose Therapeutics Corp. | 1.88 Million CAD | -122.458% |
| Defence Therapeutics Inc. | 477.74 Thousand CAD | -777.808% |
| Entheon Biomedical Corp. | 401.07 Thousand CAD | -945.609% |
| Gemina Laboratories Ltd. | 1.45 Million CAD | -187.972% |
| Glow Lifetech Corp. | 1.91 Million CAD | -119.219% |
| Lexston Life Sciences Corp. | 750.94 Thousand CAD | -458.453% |
| Pharmala Biotech Holdings Inc. | 2.41 Million CAD | -73.829% |
| Doseology Sciences Inc. | 1.1 Million CAD | -280.474% |
| MYND Life Sciences Inc. | 797.54 Thousand CAD | -425.827% |
| Nova Mentis Life Science Corp. | 31.05 Thousand CAD | -13402.363% |
| PharmaTher Holdings Ltd. | 2.58 Million CAD | -61.932% |
| PreveCeutical Medical Inc. | 181.51 Thousand CAD | -2210.451% |
| Telescope Innovations Corp. | 3.02 Million CAD | -38.701% |